InsiderClue
Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Roberto Mignone
18 Sep 2026
Director
Sell indirect
367,600
$39.06
$14.36M
Ronit Satchi-Fainaro
21 Aug 2026
Director
Sell
415
$37.25
$15.46K
Tal Zvi Zaks
5 Aug 2026
Director
Sell
17
$34.87
$592.71
Matthew Shields
18 Jun 2026
EVP, Global Operations
Sell
9,989
$32.19
$321.55K
Amir Weiss
6 May 2026
Chief Accounting Officer
Sell
10,679
$36.00
$384.44K
Richard Daniell
5 May 2026
EVP, Europe Commercial
Sell
30,000
$35.40
$1.06M
Mark Sabag
1 May 2026
See "Remarks"
Sell
144,180
$34.99
$5.05M
Christine Fox
30 Apr 2026
EVP, U.S. Commercial
Sell
21,258
$35.31
$750.62K
Mark Sabag
17 Mar 2026
See "Remarks"
Sell
62,102
$30.14
$1.87M
Roberto Mignone
16 Dec 2025
Director
Sell indirect
77,400
$30.24
$2.34M
Amir Weiss
16 Dec 2025
Chief Accounting Officer
Sell
12,300
$30.20
$371.50K
Roberto Mignone
26 Nov 2025
Director
Sell indirect
50,000
$26.03
$1.30M
Christine Fox
14 Nov 2025
EVP, Head of U.S. Commercial
Sell
30,000
$25.11
$753.32K
Amir Weiss
6 Nov 2025
Chief Accounting Officer
Sell
12,300
$24.44
$300.56K
Roberto Mignone
6 Nov 2025
Director
Sell indirect
200,000
$24.11
$4.82M
Show all 58 transactions →

What was left out

Form 4 filings counted 82
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 39
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 3,557,282
History held since 24 Jul 2008